Literature DB >> 8665790

Mechanisms of gas exchange impairment in patients with liver cirrhosis.

A G Agusti1, J Roca, R Rodriguez-Roisin.   

Abstract

This article reviews the basic pathophysiologic mechanisms underlying the abnormal pulmonary gas exchange often seen in patients with cirrhosis. To summarize, the following keypoints seem appropriate: (1) Patients with cirrhosis have a low pulmonary vascular tone characterized by a poor or absent hypoxic pressor response. This results in a marked dilation of the pulmonary vasculature. (2) This abnormal pulmonary vascular tone, independently of airway disease, causes VA/Q mismatch and mild to moderate hypoxemia. Yet, as liver disease progresses and hepatocellular function deteriorates, more severe degrees of intrapulmonary shunt emerge and, probably, O2 diffusion limitation ensues, causing severe respiratory failure (see Table 1). (3) At rest, the high cardiac output and minute ventilation of cirrhosis minimize the degree of arterial hypoxemia that otherwise would be expected from the observed degree of both VA/Q inequality and intrapulmonary shunt. During exercise, the relative "normalization' (with respect to metabolic demands) of the hemodynamic and ventilatory status of the patient explains the fall in PaO2. (4) A clear pathogenic mechanism of these pathophysiologic abnormalities is still lacking, although available evidence suggests that both the liver and the endothelial cells may play a pivotal role in the regulation of the pulmonary vascular tone in these patients. (5) To date, no pharmacologic intervention has been effective in treating hypoxemia in these patients. Yet liver transplantation helps in most of them. This observation reinforces the functional nature of the gas exchange abnormalities of cirrhosis.

Entities:  

Mesh:

Year:  1996        PMID: 8665790     DOI: 10.1016/s0272-5231(05)70298-7

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  14 in total

1.  The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.

Authors:  Wenli Yang; Junlan Zhang; Bingqian Hu; Wei Wu; Julie Venter; Gianfranco Alpini; Michael B Fallon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-07       Impact factor: 4.052

2.  Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.

Authors:  Yasumi Katsuta; Xue-Jun Zhang; Masaru Ohsuga; Toshio Akimoto; Hirokazu Komeichi; Shuji Shimizu; Yoshihito Kato; Akiko Miyamoto; Katsuaki Satomura; Teruo Takano
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

3.  The cardiac response to exercise in cirrhosis.

Authors:  F Wong; N Girgrah; J Graba; Y Allidina; P Liu; L Blendis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study.

Authors:  J J Vettukattil; Z Slavik; R K Lamb; J L Monro; B R Keeton; V T Tsang; A J Aldous; A Zivanovic; S Johns; V Lewington; A P Salmon
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

Review 5.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 6.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

7.  Arterial hypoxaemia in cirrhosis: fact or fiction?

Authors:  S Møller; J Hillingsø; E Christensen; J H Henriksen
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

8.  Evolution of gas exchange abnormalities in patients with liver cirrhosis candidate for liver transplantation.

Authors:  S M A Ghayumi; S Mehrabi; M Hoseini Asl
Journal:  Iran Red Crescent Med J       Date:  2012-03-01       Impact factor: 0.611

9.  Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS).

Authors:  Wenli Yang; Bingqian Hu; Wei Wu; Sachin Batra; Michael R Blackburn; Joseph L Alcorn; Michael B Fallon; Junlan Zhang
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

10.  Oxidative stress and pulmonary changes in experimental liver cirrhosis.

Authors:  Renata Salatti Ferrari; Darlan Pase da Rosa; Luiz Felipe Forgiarini; Silvia Bona; Alexandre Simões Dias; Norma Possa Marroni
Journal:  Oxid Med Cell Longev       Date:  2012-12-17       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.